Wales: Further Devolution

Lord Hunt of Kings Heath Excerpts
Tuesday 25th November 2025

(1 day, 3 hours ago)

Lords Chamber
Read Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Baroness Anderson of Stoke-on-Trent Portrait Baroness Anderson of Stoke-on-Trent (Lab)
- View Speech - Hansard - - - Excerpts

The noble Lord raises an interesting point. There are still six months until the elections, and I would expect to see another Labour Administration elected next year. We will be working hard to deliver, as we do every day for the people of Wales and for the people of the United Kingdom. With regard to the substance of his point, that is the first time that it has been raised with me. I will speak to officials, and I would ask him to come forward if there are any problems or challenges.

Lord Hunt of Kings Heath Portrait Lord Hunt of Kings Heath (Lab)
- View Speech - Hansard - -

Does my noble friend agree that testimony to the working relationship between the UK Government and Wales is the decision about the SMR development at Wylfa, which is welcome and which I earnestly hope will add to the growth potential of the Welsh economy?

Baroness Anderson of Stoke-on-Trent Portrait Baroness Anderson of Stoke-on-Trent (Lab)
- View Speech - Hansard - - - Excerpts

Many Members of your Lordships’ House were delighted to see the Prime Minister with the First Minister in Wylfa earlier this month announcing investment of £2.5 billion, which will create 3,000 jobs. It is a true recognition of our faith in, and the ability of, the Welsh economy, and it will drive growth for the Welsh economy.

Horizon 2020

Lord Hunt of Kings Heath Excerpts
Monday 27th January 2020

(5 years, 9 months ago)

Lords Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Lord Hunt of Kings Heath Portrait Lord Hunt of Kings Heath (Lab)
- Hansard - -

My Lords, one reason for our strong science base is our life sciences. The Minister will know that part of that depends on the interrelationship with the pharmaceutical industry and the investment that it puts into R&D. If we are to be non-aligned with the EU, many new drug developments in the UK will be at risk, because no company will want a licence in the UK before obtaining a European licence. Is that being factored into the discussions in relation to the European Medicines Agency and our own MHRA?